| ［1］ |
Duan WJ, He RR. Cuproptosis: copper-induced regulated cell death［J］. Sci China Life Sci, 2022, 65（ 8 ）: 1680-1682.
|
| ［2］ |
Tsvetkov P, Coy S, Petrova B, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins［J］. Science, 2022, 375（ 6586 ）: 1254-1261.
|
| ［3］ |
Tsang T, Davis CI, Brady DC. Copper biology［J］. CurrBiol, 2021,31（ 9 ）: R421-R427.
|
| ［4］ |
Cobine PA, Brady DC. Cuproptosis: Cellular and molecular mechanisms underlying copper-induced cell death［J］. Mol Cell,2022, 82（ 10 ）: 1786-1787.
|
| ［5］ |
Yu Q, Xiao Y, Guan M, et al. Copper metabolism in osteoarthritis and its relation to oxidative stress and ferroptosis in chondrocytes［J/OL］. Front Mol Biosci, 2024, 11: 1472492. DOI:10.3389/fmolb.2024.1472492.
|
| ［6］ |
Yang WM, Lv JF, Wang YY, et al. The daily intake levels of copper,selenium, and zinc are associated with osteoarthritis but not with rheumatoid arthritis in a cross-sectional study［J］. Biol Trace Elem Res, 2023, 201（ 12 ）: 5662-5670.
|
| ［7］ |
Tsvetkov P, Detappe A, Cai K, et al. Mitochondrial metabolism promotes adaptation to proteotoxic stress［J］. Nat Chem Biol, 2019,15（ 7 ）: 681-689.
|
| ［8］ |
Corsello SM, Nagari RT, Spangler RD, et al. Discovering the anticancer potential of non-oncology drugs by systematic viability profiling［J］. Nat Cancer, 2020, 1（ 2 ）: 235-248.
|
| ［9］ |
Hunsaker EW, Franz KJ. Emerging opportunities to manipulate metal trafficking for therapeutic benefit［J］. Inorg Chem, 2019, 58（ 20 ）: 13528-13545.
|
| ［10］ |
Oliveri V. Biomedical applications of copper ionophores［J/OL］. Coord Chem Rev, 2020, 422: 213474. DOI:10.1016/j.ccr.2020.213474.
|
| ［11］ |
Wang Y, Zhang L, Zhou F. Cuproptosis: a new form of programmed cell death［J］. Cell Mol Immunol, 2022, 19（ 8 ）: 867-868.
|
| ［12］ |
Wallace DC. A mitochondrial bioenergetic etiology of disease［J］. J Clin Invest, 2013, 123（ 4 ）: 1405-1412.
|
| ［13］ |
Blanco FJ, Valdes AM, Rego-Pérez I. Mitochondrial DNA variation and the pathogenesis of osteoarthritis phenotypes［J］. Nat Rev Rheumatol, 2018, 14（ 6 ）: 327-340.
|
| ［14］ |
López-Armada MJ, Caramés B, Martín MA, et al. Mitochondrial activity is modulated by TNFα and IL-1β in normal human chondrocyte cells［J］. Osteoarthr Cartil, 2006, 14（ 10 ）: 1011-1022.
|
| ［15］ |
Zhu X, Boulet A, Buckley KM, et al. Mitochondrial copper and phosphate transporter specificity was defined early in the evolution of eukaryotes［J/OL］. eLife, 2021, 10: e64690. DOI:10.7554/eLife.64690.
|
| ［16］ |
Prohaska JR. Role of copper transporters in copper homeostasis［J］.Am J Clin Nutr, 2008, 88（ 3 ）: 826S-829S.
|
| ［17］ |
胡浩然, 谢雪涛, 张长青. 骨关节炎中软骨细胞自噬的研究进展［J/CD］. 中华关节外科杂志（ 电子版 ）, 2018,12（ 6 ）: 826-829.
|
| ［18］ |
Xue Q, Kang R, Klionsky DJ, et al. Copper metabolism in cell death and autophagy［J］. Autophagy, 2023, 19（ 8 ）: 2175-2195.
|
| ［19］ |
Liu S, Pan Y, Li T, et al. The role of regulated programmed cell death in osteoarthritis: from pathogenesis to therapy［J/OL］. Int J Mol Sci, 2023, 24（ 6 ）: 5364. DOI:10.3390/ijms24065364.
|
| ［20］ |
Zhu Y, Wu G, Yan W, et al. miR-146b-5p regulates cell growth,invasion, and metabolism by targeting PDHB in colorectal cancer［J］. Am J Cancer Res, 2017, 7（ 5 ）: 1136-1150.
|
| ［21］ |
Saunier E, Benelli C, Bortoli S. The pyruvate dehydrogenase complex in cancer: an old metabolic gatekeeper regulated by new pathways and pharmacological agents［J］. Int J Cancer, 2016, 138（ 4 ）: 809-817.
|
| ［22］ |
Smolle M, Lindsay JG. Molecular architecture of the pyruvate dehydrogenase complex: bridging the gap［J］. Biochem Soc Trans,2006, 34（ Pt 5 ）: 815-818.
|
| ［23］ |
Park S, Baek IJ, Ryu JH, et al. PPARα-ACOT12 axis is responsible for maintaining cartilage homeostasis through modulating de novo lipogenesis［J/OL］. Nat Commun, 2022, 13（ 1 ）: 3. DOI:10.1038/s41467-021-27738-y.
|
| ［24］ |
王伟伟, 欧志学, 周毅, 等. 铜死亡基因在骨关节炎免疫浸润中的生物信息学分析［J］. 中国组织工程研究, 2023, 27（ 11 ）:1669-1676.
|
| ［25］ |
Guo W, Wei B, Sun J, et al. Suppressive oligodeoxynucleotideinduced dendritic cells rein the aggravation of osteoarthritis in mice［J］. Immunopharm Immunot, 2018, 40（ 5 ）: 430-436.
|
| ［26］ |
Wang Z, Wang B, Zhang J, et al. Chemokine （ C-C motif ） ligand 2/chemokine receptor 2 （ CCR2 ） axis blockade to delay chondrocyte hypertrophy as a therapeutic strategy for osteoarthritis［J/OL］. Med SciMonit, 2021, 27: e930053. DOI:10.12659/MSM.930053.
|
| ［27］ |
Mayr JA, Feichtinger RG, Tort F, et al. Lipoic acid biosynthesis defects［J］. J Inherit Metab Dis, 2014, 37（ 4 ）: 553-563.
|
| ［28］ |
Frommer KW, Hasseli R, Schäffler A, et al. Free fatty acids in bone pathophysiology of rheumatic diseases［J/OL］. Front Immunol,2019, 10: 2757. DOI:10.3389/fimmu.2019.02757.
|
| ［29］ |
Chen B, Hong H, Sun Y, et al. Role of macrophage polarization in osteoarthritis （ review ）［J/OL］. Exp Ther Med, 2022, 24（ 6 ）: 757.DOI:10.3892/etm.2022.11693.
|
| ［30］ |
Xu M, Ji Y. Immunoregulation of synovial macrophages for the treatment of osteoarthritis［J/OL］. Open Life Sci, 2023, 18（ 1 ）:20220567. DOI:10.1515/biol-2022-0567.
|
| ［31］ |
Li S, Zhang L, Liu C, et al. Spontaneous immunomodulation and regulation of angiogenesis and osteogenesis by Sr/Cu-borosilicate glass （ BSG ） bone cement to repair critical bone defects［J］. Bioact Mater, 2023, 23: 101-117.
|
| ［32］ |
Cen D, Brayton D, Shahandeh B, et al. Disulfiram facilitates intracellular Cu uptake and induces apoptosis in human melanoma cells［J］. J Med Chem, 2004, 47（ 27 ）: 6914-6920.
|
| ［33］ |
Nagai M, Vo NH, Shin Ogawa L, et al. The oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells［J］. Free Radic Biol Med, 2012, 52（ 10 ）:2142-2150.
|
| ［34］ |
Springer C, Humayun D, Skouta R. Cuproptosis: unraveling the mechanisms of copper-induced cell death and its implication in cancer therapy［J］. Cancers, 2024, 16（ 3 ）: 647 DOI:10.3390/cancers16030647.
|
| ［35］ |
Ruiz LM, Libedinsky A, Elorza AA. Role of copper on mitochondrial function and metabolism［J/OL］. Front Mol Biosci, 2021, 8:711227. DOI:10.3389/fmolb.2021.711227.
|
| ［36］ |
Gohil VM. Repurposing elesclomol, an investigational drug for the treatment of copper metabolism disorders［J］. Expert Opin Investig Drugs, 2021, 30（ 1 ）: 1-4.
|
| ［37］ |
Dreishpoon MB, Bick NR, Petrova B, et al. FDX1 regulates cellular protein lipoylation through direct binding to LIAS［J/OL］. bioRxiv,2023: 2023.02.03.526472. DOI:10.1101/2023.02.03.526472.
|
| ［38］ |
Li SR, Bu LL, Cai L. Cuproptosis: lipoylated TCA cycle proteinsmediated novel cell death pathway［J/OL］. Signal Transduct Target Ther, 2022, 7（ 1 ）: 158. DOI:10.1038/s41392-022-01014-x.
|
| ［39］ |
Tang D, Chen X, Kroemer G. Cuproptosis: a copper-triggered modality of mitochondrial cell death［J］. Cell Res, 2022, 32（ 5 ）:417-418.
|
| ［40］ |
Yang S, Li Y, Zhou L, et al. Copper homeostasis and cuproptosis in atherosclerosis: metabolism, mechanisms and potential therapeutic strategies［J/OL］. Cell Death Discov, 2024, 10（ 1 ）: 25.DOI:10.1038/s41420-023-01796-1.
|
| ［41］ |
Solmonson A, DeBerardinis RJ. Lipoic acid metabolism and mitochondrial redox regulation［J］. J Biol Chem, 2018, 293（ 20 ）:7522-7530.
|
| ［42］ |
Rowland EA, Snowden CK, Cristea IM. Protein lipoylation:an evolutionarily conserved metabolic regulator of health and disease［J］. Curr Opin Chem Biol, 2018, 42: 76-85.
|
| ［43］ |
Tang Q, Guo Y, Meng L, et al. Chemical tagging of protein lipoylation［J］. Angew Chem Int Ed, 2021, 60（ 8 ）: 4028-4033.
|
| ［44］ |
Gao L, Zhang A. Copper-instigated modulatory cell mortality mechanisms and progress in oncological treatment investigations［J/OL］. Front Immunol, 2023, 14: 1236063. DOI:10.3389/fimmu.2023.1236063.
|
| ［45］ |
de Goede P, Wefers J, Brombacher EC, et al. Circadian rhythms in mitochondrial respiration［J］. J Mol Endocrinol, 2018, 60（ 3 ）:R115-R130.
|
| ［46］ |
Stockwell BR. Ferroptosis turns 10: Emerging mechanisms,physiological functions, and therapeutic applications［J］. Cell, 2022,185（ 14 ）: 2401-2421.
|
| ［47］ |
Guan M, Yu Q, Zhou G, et al. Mechanisms of chondrocyte cell death in osteoarthritis: implications for disease progression and treatment［J/OL］. J Orthop Surg Res, 2024, 19（ 1 ）: 550.DOI:10.1186/s13018-024-05055-6.
|
| ［48］ |
Zhu C, Han S, Zeng X, et al. Multifunctional thermo-sensitive hydrogel for modulating the microenvironment in Osteoarthritis by polarizing macrophages and scavenging RONS［J/OL］. J Nanobiotechnol, 2022, 20（ 1 ）: 221. DOI:10.1186/s12951-022-01422-9.
|
| ［49］ |
Qi H, Shi H, Yan M, et al. Ammonium tetrathiomolybdate relieves oxidative stress in cisplatin-induced acute kidney injury via NRF2 signaling pathway［J/OL］. Cell Death Discov, 2023, 9（ 1 ）: 259.DOI:10.1038/s41420-023-01564-1.
|
| ［50］ |
Sang Y, Zhang J, Liu C, et al. Ameliorating osteoarthritis in mice using silver nanoparticles［J/OL］. J Vis Exp, 2023（ 196 ）: （ 196 ）.DOI:10.3791/65111.
|
| ［51］ |
Rellmann Y, Eidhof E, Dreier R. Review: ER stress-induced cell death in osteoarthritic cartilage［J/OL］. Cell Signal, 2021, 78:109880. DOI:10.1016/j.cellsig.2020.109880.
|
| ［52］ |
颜春鲁, 安方玉, 汪永锋, 等. 右归丸对大鼠膝骨关节炎的干预作用及其机制［J］. 中国应用生理学杂志, 2020,36（ 5 ）: 511-516.
|
| ［53］ |
杨永菊, 任艳玲, 郑曲, 等. 右归丸治疗膝骨性关节炎作用机制的研究进展［J］. 中华中医药学刊, 2022,40（ 7 ）: 59-62.
|